An eye’s view of T regulatory cells
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
T regulatory (Treg) cells have been studied for more than 30 years. Recently, changing technology and attitudes have led to new interest in T cell regulation of the immune responses. The eye is an immune-privileged site with unique mechanisms for the prevention of damaging immune inflammation. The eye fashions its Treg cells in novel ways to prevent immune inflammation locally and systemically. The purpose of this mini-review is to condense and summarize reports of Treg cells dependent on the eye in the context of the Treg literature in general.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669 · cited 1×
“Although T cells that regulate the immune response may be CD4 or CD8 , the most frequently studied Treg cells are CD4 CD25 cells, which arise naturally within the thymus [16].”
BackgroundCD4+CD25+ Immunoregulatory T Cells
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., & Byrne, M. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00280-7 · Cited by 1,395
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807 · cited 3×
“Amongst the most-studied models of immune privilege is the model of peripheral tolerance induction in the eye, called anterior chamber-associated immune deviation (ACAID) [41].”
BackgroundResultSTEIN-STREILEIN, J., & STREILEIN, J. W. (2002) · International Reviews of Immunology · doi:10.1080/08830180212066 · Cited by 218 · cited 2×
“lines the posterior surface of the iris, the ciliary body, and neural retina and thus, partially surrounds the privileged sites [41] of the anterior chamber [31], the vitreous cavity [88], and the subretinal space [89, 90], respectively.”
BackgroundSelf-citationSuter, T., Biollaz, G., Gatto, D., Bernasconi, L., Herren, T., Reith, W., & Fontana, A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323611 · Cited by 114
Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye
Cousins, S. W., Trattler, W. B., & Streilein, J. W. (1991) · Current Eye Research · doi:10.3109/02713689108996334 · Cited by 85 · cited 1×
“The presence of such factors was first demonstrated by the ability of healthy, aqueous humor to suppress IFN- production by Th1 cells [68, 70].”
Background
Cited by
A look at autoimmunity and inflammation in the eye
Caspi, R. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42440 · Cited by 482
Gene therapy and genome surgery in the retina
DiCarlo, J. E., Mahajan, V. B., & Tsang, S. H. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120429 · Cited by 127
“Immunosuppressive cytokines and surface molecules displayed on ocular parenchymal cells, which interact with Tregs to dampen inflammatory responses, also contribute to the eye’s immune-privileged state (1, 3).”
BackgroundImmunology of AAV-Mediated Gene Transfer in the Eye
Willett, K., & Bennett, J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00261 · Cited by 105
“Treg cells are CD25 and FoxP3 and contain sub-populations of CD4 “afferent” cells that suppress initiation of Th1 cells and CD8 “efferent” cells that suppress Th1 action (18).”
BackgroundImmune regulation and the eye.
Stein-Streilein, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.08.002 · Cited by 99
Self-citation
Metadata
- Authors
- Stein-Streilein, J., & Taylor, A. W.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-12-28
- Volume
- 81
- Issue
- 3
- Pages
- 593-598
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2142953619
- Cited by
- 48
- References
- 6
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.